Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial-Reference-Cited by-同舟云学术

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Published:2017-12 Issue:12 Volume:18 Page:1600-1609
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Brahmer Julie R,Rodríguez-Abreu Delvys,Robinson Andrew G,Hui Rina,Csőszi Tibor,Fülöp Andrea,Gottfried Maya,Peled Nir,Tafreshi Ali,Cuffe Sinead,O'Brien Mary,Rao Suman,Hotta Katsuyuki,Zhang Jin,Lubiniecki Gregory M,Deitz Anne C,Rangwala Reshma,Reck Martin

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

2. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany;Iyer;Lung Cancer,2013

3. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study;Iyer;Support Care Cancer,2014

4. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer;Temel;Clin Lung Cancer,2006

5. Symptoms in adults with lung cancer. A systematic research review;Cooley;J Pain Symptom Manag,2000

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

2. Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study;Frontiers in Pharmacology;2024-09-06

3. Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: insights from the FAERS database;Frontiers in Pharmacology;2024-08-21

4. Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients;Journal of Clinical Medicine;2024-08-20

5. Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer;Thoracic Cancer;2024-08-04